5 recruiting, 4 completed, 3 withdrawn, 1 unknown. 6 Phase 3, 3 Phase 2, 2 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Recruiting 3, Completed 2, Withdrawn 1 |
| Phase 2 | 3 | Recruiting 2, Withdrawn 1 |
| Not applicable | 2 | Recruiting 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Colon Cancer Stage III: new trials by email Literature Review of Colon Cancer Stage III trials Research Report on Colon Cancer Stage III
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Survival Outcomes by Tumor-Node Stage and Recurrence Patterns in Colon Cancer After Radical Surgery Colon Cancer, Colon Adenocarcinoma | Completed | Chang Gung Memorial Hospital | 7259 | 2025-04-09 | 2025-09-11 | |
| Phase II Study of Neoadjuvant Dostarlimab in Patients With Untreated T3-4N0-2 or Stage III pMMR/MSS Resectable Colon Cancer Dostarlimab - Colon Cancer Stage III | Phase 2 | Recruiting | Universitaire Ziekenhuizen KU Leuven | 10 | 2025-04-03 | 2026-02-12 |
| The Effects of Chiropractic in Adults With Colon Cancer HVLA cervical chiropractic adjustments - Colon Cancer Stage III, Colon Cancer Stage IV | Not applicable | Withdrawn | Life University | 2025-01-01 | 2024-04-03 | |
| Immunoscore As Decision Guidance for Adjuvant Chemotherapy in Colon Cancer Capecitabine, Oxaliplatin, Fluorouracil - Colon Cancer Stage III | Phase 3 | Withdrawn | Johannes Laengle, MD, PhD | 2024-12-01 | 2024-09-20 | |
| The Sagittarius Trial Oxaliplatin, Capecitabine, Folinic acid - Colon Cancer Stage II, Colon Cancer Stage III | Phase 3 | Recruiting | IFOM ETS - The AIRC Institute of Molecular Oncology | 700 | 2024-10-22 | 2025-08-29 |
| Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer ChlorproMAZINE 50 MG, Control - Colon Cancer Stage III | Phase 1 / Phase 2 | Withdrawn | Sadat City University | 2022-07-20 | 2022-10-27 | |
| Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers neoadjuvant chemotherapyI, Colectomy, adjuvant chemotherapy - Colon Cancer Stage II, Colon Cancer Stage III | Phase 3 | Recruiting | Sun Yat-sen University | 840 | 2021-12-01 | 2022-01-18 |
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes PICO G2 4k - Cancer Pain, Visceral Pain | Not applicable | Recruiting | Cedars-Sinai Medical Center | 360 | 2021-10-05 | 2026-02-20 |
| Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer mFOLFIRINOX, mFOLFOX 6 - Colon Cancer Stage III | Phase 2 / Phase 3 | Recruiting | Chungnam National University Hospital | 308 | 2021-07-06 | 2026-03-19 |
| ArTificial inTelligence-based RAdiogenomics in Colon Tumors Colon Cancer Stage II, Colon Cancer Stage III | Unknown | University of Roma La Sapienza | 500 | 2021-01-02 | 2023-10-31 | |
| Lymph Node Ratio and Kras Mutation in R Colon Cancer k ras, Panitumumab - Colon Cancer Stage III | Phase 3 | Completed | Mansoura University | 433 | 2017-03-10 | 2020-04-13 |
| Five-year Recurrence After LCME LCME training programme - Colon Cancer Stage I, Colon Cancer Stage II | Completed | Gødstrup Hospital | 2529 | 2015-01-01 | 2025-12-09 | |
| Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C 5-fluorouracil, levamisol, interferon - Colon Cancer Stage III | Phase 3 | Completed | Austrian Breast & Colorectal Cancer Study Group | 598 | 1990-10-01 | 2006-04-03 |
Colonic Neoplasms (13) · Recurrence (2) · Anus Neoplasms (1) · Appendiceal Neoplasms (1) · Bile Duct Neoplasms (1) · Biliary Tract Neoplasms (1) · Cancer Pain (1) · Carcinoid Tumor (1) · Esophageal Neoplasms (1) · Gallbladder Neoplasms (1) · Gastrointestinal Neoplasms (1) · Liver Neoplasms (1) · Motor Activity (1) · Neoplasm Metastasis (1) · Neuroendocrine Tumors (1)
Colonic Diseases (13) · Colorectal Neoplasms (13) · Digestive System Diseases (13) · Digestive System Neoplasms (13) · Gastrointestinal Diseases (13) · Intestinal Diseases (13) · Intestinal Neoplasms (13) · Neoplasms (13) · Neoplasms by Site (13) · Gastrointestinal Neoplasms (12) · Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Adenocarcinoma (1) · Anus Diseases (1)
Fluorouracil (3) · Capecitabine (2) · Leucovorin (2) · Oxaliplatin (2) · Panitumumab (2) · Chemotherapy, Adjuvant (1) · Chlorpromazine (1) · Colectomy (1) · Exercise (1) · Folfox protocol (1) · Interferons (1) · Ipilimumab (1) · Irinotecan (1) · Levamisole (1) · Nivolumab (1)
Austrian Breast & Colorectal Cancer Study Group (1) · Cedars-Sinai Medical Center (1) · Chang Gung Memorial Hospital (1) · Chungnam National University Hospital (1) · Gødstrup Hospital (1) · IFOM ETS - The AIRC Institute of Molecular Oncology (1) · Johannes Laengle, MD, PhD (1) · Life University (1) · Mansoura University (1) · Sadat City University (1) · Sun Yat-sen University (1) · Universitaire Ziekenhuizen KU Leuven (1) · University of Roma La Sapienza (1)
Austria (2) · Egypt (2) · Italy (2) · United States (2) · Belgium (1) · China (1) · Germany (1) · South Korea (1) · Spain (1) · Taiwan (1)
Andrea Laghi, MD (1) · Brennan Spiegel, MD, MSHS (1) · Clara Montagut (1) · Kyung Ha Lee (1) · Raimund Jakesz, MD (1) · Sabine Tejpar, MD (1) · Scott Irwin, MD, PhD (1) · Stephanie Sullivan, DC, PhD (1) · Tawfik A Elkhodary, MD (1) · Yoram Gidron, PhD (1)
2023 (1), R01CA252211 (1)